Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
<h4>Aim</h4>To evaluate the efficacy and safety of bevacizumab in the adjuvant cancer therapy setting within different subset of patients.<h4>Methods & design/ results</h4>PubMed, EMBASE, Cochrane and Clinical trials.gov databases were searched for English language studie...
Saved in:
Main Authors: | Fariba Ahmadizar, N Charlotte Onland-Moret, Anthonius de Boer, Geoffrey Liu, Anke H Maitland-van der Zee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0136324 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Future of Pharmacogenetics in Cardiovascular Diseases
by: Schie, Rianne M.F. Van, et al.
Published: (2012) -
Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.
by: Grace Wangge, et al.
Published: (2010-10-01) -
Efficacy and safety of bevacizumab biosimilar SIBP04 compared with bevacizumab (Avastin®) as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lung cancer: A randomized, double-blind, phase 3 trial
by: Yuankai Shi, et al.
Published: (2025-07-01) -
The Role of Adjuvant Immunomodulatory Agents for Treatment of Severe Influenza
Published: (2018-02-01) -
The Bevacizumab “Pseudoresponse” in Glioma: Disappointment or Opportunity?
by: Thomas, Piia, et al.
Published: (2011)